Immunohistochemistry of thrombi following iliac venous stenting: A novel model of venous thrombosis

Thrombosis and Haemostasis

Volumn 96, Issue 5, 2006, Pages 618-622

  Burches, Bobby ^b   Karnicki, Krzysztof ^a   Wysokinski, Waldemar ^a   McBane II, Robert D ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Platelets; Vascular stents; Venous thrombosis

Indexed keywords

FIBRINOGEN; INDIUM 111; MONOCLONAL ANTIBODY; PROTHROMBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; ILIAC VEIN; IMMUNOHISTOCHEMISTRY; LEUKOCYTE AGGREGATION; LEUKOCYTE COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; SCINTIPHLEBOGRAPHY; STATISTICAL SIGNIFICANCE; STENT; SWINE; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOGENESIS; VEIN THROMBOSIS;

ANIMALS; BLOOD PLATELETS; CELL ADHESION; CELL COUNT; FIBRIN; ILIAC VEIN; IMMUNOHISTOCHEMISTRY; LEUKOCYTES; MODELS, ANIMAL; STENTS; SWINE; VENOUS THROMBOSIS;

EID: 33751236782     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1106/Th06-07-0364     Document Type: Article

References (19)

1. Thomas ICH, Zierler BK. An integrative review of outcomes in patients with acute primary upper extremity deep venous thrombosis following no treatment or treatment with anticoagulation, thrombolysis, or surgical algorithms. Vasc Endovasc Surg 2005; 39: 163-74.
2. Mewissen MW, et al. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology 1999; 211: 39-49.
3. AbuRahma AF, et al. Iliofemoral deep vein thrombosis: conventional therapy versus lysis and percutaneous transluminal angioplasty and stenting. Ann Surg 2001; 233: 752-60.
4. Vedantham S, et al. Pharmacomechanical thrombolysis and early stent placement for iliofemoral deep vein thrombosis. J Vase Intervent Radiol 2004; 15: 565-74.
5. Augustinos P, Ouriel K. Invasive approaches to treatment of venous thromboembolism. Circulation 2004; 110: 127-34.
6. Mickley V, et al. Stenting of central venous stenoses in hemodialysis patients: long-term results. Kidney Int 1997; 51: 277-80.
7. Blattler W, Blattler IK. Relief of obstructive pelvic venous symptoms with endoluminal stenting. J Vasc Surg 1999; 29: 484-8.
8. Ko GY, et al. Endovascular treatment of hepatic venous outflow obstruction after living-donor liver transplantation. J Vase Intervent Radiol 2002; 13: 591-9.
9. Caldarone CA, et al. Relentless pulmonary vein stenosis after repair of total anomalous pulmonary venous drainage. Ann Thorac Surg 1998; 66: 1514-20.
10. McBane RD, et al. Antithrombotic action of endogenous porcine protein C activated with a latent porcine thrombin preparation. Thromb Haemost 1995; 74: 879-85.
11. Wysokinski WE, et al. Atrial fibrillation and thrombosis: immunchistochemical differences between in situ and embolized thrombi. J Thromb Haemost 2004; 2: 1637-44.
12. Myers DD Jr, et al. Decreased venous thrombosis with an oral inhibitor of P selectin. J Vase Surg 2005; 42: 329-36.
13. Sevitt S. The structure and growth of valve-pocket thrombi in femoral veins. J Clin Path 1974; 27: 517-28.
14. Malone PC. A hypothesis concerning the aetiology of venous thrombosis. Med Hypoth 1977; 3: 189-201.
15. Schaub RG, et al. Early events in the formation of a venous thrombus following local trauma and stasis. Lab Invest 1984; 51: 218-24.
16. Thomas DP. Venours thrombosis and the "Wessler" test. Thromb Haemost 1996; 76: 1-4.
17. Neglen P, Raju S. In-stent recurrent stenosis in stents placed in the lower extremity venous outflow tract. J Vasc Surg 2004; 39: 181-7.
18. Heckenkamp J, et al. Vascular restenosis. Basic science and clinical implications. J Cardiovasc Surg 2002; 43: 349-57.
19. Bjarnason H, et al. Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vase Intervent Radiol 1997; 8: 405-18.